BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 34908226)

  • 1. Benchmark dose modelling in regulatory ecotoxicology, a potential tool in pest management.
    Jensen SM; Kluxen FM; Ritz C
    Pest Manag Sci; 2022 May; 78(5):1772-1779. PubMed ID: 34908226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bootstrap estimation of benchmark doses and confidence limits with clustered quantal data.
    Zhu Y; Wang T; Jelsovsky JZ
    Risk Anal; 2007 Apr; 27(2):447-65. PubMed ID: 17511711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the lower limit of benchmark dose confidence interval with no-observed-adverse-effect level by applying four different software for tumorigenicity testing of pesticides in Japan.
    Yasuhiko Y; Ishigami M; Machino S; Fujii T; Aoki M; Irie F; Kanda Y; Yoshida M
    Regul Toxicol Pharmacol; 2022 Aug; 133():105201. PubMed ID: 35691450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the benchmark dose for point of departure determination for a variety of chemical classes in applied regulatory settings.
    Izadi H; Grundy JE; Bose R
    Risk Anal; 2012 May; 32(5):830-5. PubMed ID: 22126138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does EU legislation allow the use of the Benchmark Dose (BMD) approach for risk assessment?
    Brandon EF; Bulder AS; van Engelen JG; Mahieu CM; Mennes WC; Pronk ME; Rietveld AG; van de Ven BM; Ten Voorde SE; Wolterink G; Slob W; Zeilmaker MJ; Bessems JG
    Regul Toxicol Pharmacol; 2013 Nov; 67(2):182-8. PubMed ID: 23871753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of benchmark dose models in risk assessment for occupational handlers of eight pesticides used in pome fruit production.
    Pouzou JG; Kissel J; Yost MG; Fenske RA; Cullen AC
    Regul Toxicol Pharmacol; 2020 Feb; 110():104504. PubMed ID: 31655092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The benchmark dose method--review of available models, and recommendations for application in health risk assessment.
    Filipsson AF; Sand S; Nilsson J; Victorin K
    Crit Rev Toxicol; 2003; 33(5):505-42. PubMed ID: 14594105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of a site-specific reference dose for methylmercury for fish-eating populations.
    Shipp AM; Gentry PR; Lawrence G; Van Landingham C; Covington T; Clewell HJ; Gribben K; Crump K
    Toxicol Ind Health; 2000 Nov; 16(9-10):335-438. PubMed ID: 11762928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An evaluation of benchmark dose methodology for non-cancer continuous-data health effects in animals due to exposures to dioxin (TCDD).
    Gaylor DW; Aylward LL
    Regul Toxicol Pharmacol; 2004 Aug; 40(1):9-17. PubMed ID: 15265602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Introduction to benchmark dose methods and U.S. EPA's benchmark dose software (BMDS) version 2.1.1.
    Davis JA; Gift JS; Zhao QJ
    Toxicol Appl Pharmacol; 2011 Jul; 254(2):181-91. PubMed ID: 21034758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Derivation of point of departure (PoD) estimates in genetic toxicology studies and their potential applications in risk assessment.
    Johnson GE; Soeteman-Hernández LG; Gollapudi BB; Bodger OG; Dearfield KL; Heflich RH; Hixon JG; Lovell DP; MacGregor JT; Pottenger LH; Thompson CM; Abraham L; Thybaud V; Tanir JY; Zeiger E; van Benthem J; White PA
    Environ Mol Mutagen; 2014 Oct; 55(8):609-23. PubMed ID: 24801602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The benchmark dose approach in food risk assessment: is it applicable and worthwhile?
    Muri SD; Schlatter JR; Brüschweiler BJ
    Food Chem Toxicol; 2009 Dec; 47(12):2906-25. PubMed ID: 19682530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of subchronic toxicity data using the benchmark dose approach.
    Gephart LA; Salminen WF; Nicolich MJ; Pelekis M
    Regul Toxicol Pharmacol; 2001 Feb; 33(1):37-59. PubMed ID: 11259178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The current state of knowledge on the use of the benchmark dose concept in risk assessment.
    Sand S; Victorin K; Filipsson AF
    J Appl Toxicol; 2008 May; 28(4):405-21. PubMed ID: 17879232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deriving a data-based interspecies assessment factor using the NOAEL and the benchmark dose approach.
    Bokkers BG; Slob W
    Crit Rev Toxicol; 2007 Jun; 37(5):355-73. PubMed ID: 17612951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benchmark dose and the three Rs. Part I. Getting more information from the same number of animals.
    Slob W
    Crit Rev Toxicol; 2014 Aug; 44(7):557-67. PubMed ID: 25000332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Web-Based System for Bayesian Benchmark Dose Estimation.
    Shao K; Shapiro AJ
    Environ Health Perspect; 2018 Jan; 126(1):017002. PubMed ID: 29329100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benchmark dose calculation for ordered categorical responses.
    Chen CC; Chen JJ
    Risk Anal; 2014 Aug; 34(8):1435-47. PubMed ID: 24444309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of the benchmark dose in a regulatory context.
    Travis KZ; Pate I; Welsh ZK
    Regul Toxicol Pharmacol; 2005 Dec; 43(3):280-91. PubMed ID: 16143439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A procedure for developing risk-based reference doses.
    Gaylor DW; Kodell RL
    Regul Toxicol Pharmacol; 2002 Apr; 35(2 Pt 1):137-41. PubMed ID: 12051999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.